- Home
- AXSM vs ELP Comparison
AXSM vs ELP Comparison
Compare AXSM & ELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- ELP
- Stock Information
- Founded
- AXSM 2012
- ELP 1954
- Country
- AXSM United States
- ELP Brazil
- Employees
- AXSM N/A
- ELP N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- ELP Electric Utilities: Central
- Sector
- AXSM Health Care
- ELP Utilities
- Exchange
- AXSM Nasdaq
- ELP Nasdaq
- Market Cap
- AXSM 5.9B
- ELP 7.1B
- IPO Year
- AXSM 2015
- ELP 1997
- Fundamental
- Price
- AXSM $135.51
- ELP $10.55
- Analyst Decision
- AXSM Strong Buy
- ELP
- Analyst Count
- AXSM 19
- ELP 0
- Target Price
- AXSM $174.47
- ELP N/A
- AVG Volume (30 Days)
- AXSM 501.4K
- ELP 190.0K
- Earning Date
- AXSM 11-03-2025
- ELP 11-12-2025
- Dividend Yield
- AXSM N/A
- ELP 4.18%
- EPS Growth
- AXSM N/A
- ELP 30.24
- EPS
- AXSM N/A
- ELP 0.19
- Revenue
- AXSM $561,263,000.00
- ELP $4,381,150,343.00
- Revenue This Year
- AXSM $63.66
- ELP N/A
- Revenue Next Year
- AXSM $54.46
- ELP $6.95
- P/E Ratio
- AXSM N/A
- ELP $13.41
- Revenue Growth
- AXSM 65.83
- ELP 8.47
- 52 Week Low
- AXSM $75.56
- ELP $5.72
- 52 Week High
- AXSM $139.13
- ELP $10.56
- Technical
- Relative Strength Index (RSI)
- AXSM 67.09
- ELP 75.72
- Support Level
- AXSM $129.45
- ELP $10.17
- Resistance Level
- AXSM $136.13
- ELP $10.35
- Average True Range (ATR)
- AXSM 5.45
- ELP 0.16
- MACD
- AXSM 0.43
- ELP 0.07
- Stochastic Oscillator
- AXSM 84.66
- ELP 98.91
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About ELP Companhia Paranaense de Energia (COPEL)
Cia Paranaense De Energia Copel is engaged in the areas of generation, transmission, commercialization and distribution of energy. It operates a comprehensive and effective electrical system with its own generating plants, transmission lines, substations, electrical lines and grids of the distribution system. The company's reportable segments include Power generation and transmission, Power distribution, GAS, Power sale, Services, and Holding. The majority of its revenue is generated from the Power generation and transmission segment under which it produces electricity from hydraulic, wind, and thermal projects and provides services of transmission and transformation of electric power and other related services.